Search among the 163646 resources available in the repository
dc.date.accessioned | 2010-02-04T11:52:49Z | |
dc.date.available | 2010-02-04T03:00:00Z | |
dc.date.issued | 2009 | es |
dc.identifier.uri | http://sedici.unlp.edu.ar/handle/10915/7861 | |
dc.description.abstract | A tuberculose é uma doença negligenciada causada pelo Mycobacterium tuberculosis. São estimados dois milhões de óbitos e oito milhões de novos casos por ano, sendo 490.000 casos multi-droga resistentes. Fármacos anti-TB na forma de dose fixa combinada apresentam problemas relacionados à biodisponibilidade da rifampicina, que se relaciona com os casos de resistência. O investimento em tecnologia a fim de obter novas formas farmacêuticas tem se mostrado alternativa promissora para diminuir os casos de resistência e contribuir com a prevenção, controle e cura. | es |
dc.description.abstract | Tuberculosis is a neglected disease caused by Mycobacterium tuberculosis. Two million deaths and eight million new cases per year are estimated, with 490,000 cases multi-drug resistant. Anti-TB drugs as fixed-dose combination have problems inherent to the bioavailability of rifampicin, which is related to the cases of resistance. The investment in technology to achieve new pharmaceutical forms has shown promising alternative to reduce the cases of resistance and contribute to the prevention, control and cure. | en |
dc.format.extent | 945-948 | es |
dc.language | pt | es |
dc.subject | multi-droga resistência; novas formas farmacêuticas; prevenção e controle | es |
dc.subject | Tuberculosis | es |
dc.subject | multi-drug resistance, new pharmaceutical forms; prevention and control | en |
dc.subject | Medicamentos | es |
dc.subject | Farmacología | es |
dc.title | Novas formas farmacêuticas como alternativa para o tratamento da tuberculose visando a diminuição de casos de multi-droga resistência | es |
dc.title.alternative | New pharmaceutical forms as alternative for the treatment of tuberculosis to reduce cases of multi-drug resistance | en |
dc.type | Articulo | es |
sedici.identifier.uri | http://www.latamjpharm.org/trabajos/28/6/LAJOP_28_6_3_1_K1AADSM0N1.pdf | es |
sedici.creator.person | Cavalcanti, Aline C. | es |
sedici.creator.person | Albuquerque, Miracy M. | es |
sedici.creator.person | Medeiros, Flávia P. M. | es |
sedici.creator.person | Lavra, Zênia M.M. | es |
sedici.creator.person | Santana, Aíla K.M. | es |
sedici.subject.materias | Farmacia | es |
sedici.description.fulltext | true | es |
mods.originInfo.place | Colegio de Farmacéuticos de la Provincia de Buenos Aires | es |
sedici.subtype | Revision | es |
sedici2003.identifier | ARG-FARM-ART-0000001348 | es |
sedici.relation.journalTitle | Latin American Journal of Pharmacy | es |
sedici.relation.journalVolumeAndIssue | vol. 28, no. 6 | es |